Cargando…
New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) – The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations()
The systematic use of antivitamin K anticoagulants (AVK) as rodenticides caused the selection of rats resistant to AVKs. The resistance is mainly associated to genetic polymorphisms in the Vkorc1 gene encoding the VKORC1 enzyme responsible for the reduction of vitamin K 2,3-epoxide to vitamin K. Fiv...
Autores principales: | Matagrin, Benjamin, Hodroge, Ahmed, Montagut-Romans, Adrien, Andru, Julie, Fourel, Isabelle, Besse, Stéphane, Benoit, Etienne, Lattard, Virginie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668507/ https://www.ncbi.nlm.nih.gov/pubmed/23772386 http://dx.doi.org/10.1016/j.fob.2013.02.001 |
Ejemplares similares
-
Missense mutation of VKORC1 leads to medial arterial calcification in rats
por: Michaux, Arnaud, et al.
Publicado: (2018) -
VKORC1 and VKORC1L1: Why do Vertebrates Have Two Vitamin K 2,3-Epoxide Reductases?
por: Oldenburg, Johannes, et al.
Publicado: (2015) -
Investigation of anticoagulant rodenticide resistance induced by Vkorc1 mutations in rodents in Lebanon
por: Rached, Antoine, et al.
Publicado: (2022) -
Establishment of the Variation of Vitamin K Status According to Vkorc1 Point Mutations Using Rat Models
por: Debaux, Jean Valéry, et al.
Publicado: (2019) -
Vitamin K epoxide reductase complex subunit 1 (Vkorc1) haplotype diversity in mouse priority strains
por: Song, Ying, et al.
Publicado: (2008)